FDA Drug Application (073449) for TRIAMTERENE AND HYDROCHLOROTHIAZIDE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number073449
Product Number001
FormTABLET;ORAL
Dosage25MG;37.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRIAMTERENE AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; TRIAMTERENE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient TRIAMTERENE5


Back to FDA Applications sponsored by WATSON LABS